3 Conferences in April in the US
Haifa, Israel –March 26, 2012 -- Pluristem Therapeutics, Inc. (NasdaqCM: PSTI; TASE: PLTR) announced today that William Prather RPh, MD, Sr. VP of Corporate Development, will present at three upcoming financial and scientific events in the U.S. In addition to outlining the progress that Pluristem has made on the development of its PLacental eXpanded (PLX) cell product candidates, Dr. Prather will also speak about the recently announced pre-clinical data on acute radiation syndrome (ARS) and acute myocardial infarction (AMI), the construction of Pluristem's state-of-the-art cell therapy manufacturing facility, as well as the company's strategy of partnering with pharmaceutical companies for the marketing of several of its potential cell therapies.
Below is the schedule of events where Pluristem will be delivering presentations:
Needham Healthcare Conference
Apr 3 at 2:00PM-2:40PM in Henry New York Palace Hotel, Manhattan, New York City
Imperial Capital's Healthcare Investor Forum
April 17 at 10:15AM-10:45AM, New York Palace Hotel, Manhattan, New York City
8th Stem Cell Summit
April 19 at 3:15PM-5:45PM session and on April 20 at 10:45AM-noon session, Hyatt Harborside Hotel, Boston, MA
Dr. Prather will be speaking about "The Advantages of Expanding PLX cells Three Dimensionally"
|
